Large-scale testing (Phase 3)Ended earlyNCT00658008
What this trial is testing
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
Who this might be right for
Generalized Anxiety Disorder
Pfizer 501